Commercialization Programs

Fred Hutch researchers are eligible to apply for funding and other support to help them take their discoveries and ideas to a commercially viable stage. These funding programs include philanthropic efforts as well as collaborations with commercial entities.
 

Corporate Programs

Seattle Partnership for Research on Innovative Therapies (SPRInT)

SPRInT, an alliance between Fred Hutch, the University of Washington, Seattle Children’s Research Institute and Takeda Pharmaceuticals, provides resources and expertise to spur the discovery of novel therapeutics in the areas of oncology, gastroenterology and neuroscience. Selected projects benefit from Takeda’s proprietary research tools and product planning capabilities and are staffed and operated by joint teams from Takeda and the originating institution.

LAB591

A collaboration between Fred Hutch and two European partners — Evotec SE and Arix Bioscience plc — LAB591 aims to speed the development of new cancer and infectious disease drugs by providing funding and expertise for the formation of new companies based on discoveries made at Fred Hutch and elsewhere. The partnership is administered by the three partner institutions, and all projects are selected by a joint steering committee.

Philanthropic Programs

Evergreen Fund

The Evergreen Fund supports Fred Hutch employees in bringing their bold ideas and promising discoveries to a commercially viable stage in order to attract a licensing partner or venture funding. Two levels of support are available: pilot funding of up to $50,000, and up to $200,000 for work that has already yielded promising data and identified a commercial path forward.

HDC Accelerator Fund

The HDC Accelerator Fund provides funding to Fred Hutch employees and their collaborators for projects that use data science in biomedical research and contribute to the institution’s shared data infrastructure. The focus is on cross-discipline and cross-institution projects; external collaborators may include individuals from academic, governmental, nonprofit or industry organizations. The fund grants pilot awards of up to $50,000 and development awards of up to $150,000 in additional funding for projects that have completed the pilot phase.

Donate to a Philanthropic Commercialization Program


Fred Hutch is looking for philanthropic donors who want to contribute to the Evergreen Fund or start their own fund to help translate pathbreaking discoveries into lifesaving treatments. For more information, contact our Philanthropy team or call 206.667.7596.